Each year, nearly 130,000 people in the United States die from strokes, with many of them from intracerebral hemorrhages. In an effort to combat that, Aurora Health Care’s Aurora Research Institute has launched a multicenter research study to assess the outcomes of a unique, minimally invasive surgical approach to safely remove clots in study subjects with intracerebral hemorrhage in deep areas of the brain.
Dr. Amin Kassam, Aurora’s vice president of neurosciences, is leading the study at Aurora St. Luke’s Medical Center in Milwaukee, which serves as the national hub and coordinating site for the multicenter trial. Up to 12 sites nationwide will participate in the program.
The goal of the study is to assess clinical outcomes in up to 50 study subjects surgically treated for subcortical intracerebral hemorrhages. Investigators will also perform an economic analysis, comparing inpatient care costs of patients who undergo the unique surgical approach to those managed with drugs or conventional surgical treatment.
“The problem we have today is that a ‘wait and see’ approach to hemorrhage resolution does not always result in the best outcome for the patient,” Kassam said. “It is our hope that by using this new, integrated surgical approach of subcortical parafascicular access with early intervention, we will provide a better end-result with less trauma to the patient and improved functional outcomes.”
Intracerebral hemorrhages are a type of stroke that occurs when a blood vessel in the brain bursts, most often due to high blood pressure. The pressure from the blood leaking inside the brain can damage brain tissue and lead to permanent disability or death.